Advertisement Banner
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact
No Result
View All Result
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact
No Result
View All Result
HealthNews
No Result
View All Result
Home Health Tech News

Do I Have Alzheimer’s Disease? Just One Brain Scan May Tell

admin by admin
June 22, 2022
in News


June 22, 2022 – A single brain scan may someday offer an early diagnosis of Alzheimer’s disease.

Using artificial intelligence to look at structures in the brain, researchers in the United Kingdom developed an algorithm that can determine – with 98% accuracy – whether someone has the disease from a single MRI scan.

The tool could also tell the difference between early and late-stage dementia in 79% of cases.

“Currently, no other simple and widely available methods can predict Alzheimer’s disease with this level of accuracy, so our research is an important step forward,” Eric Aboagye, PhD, a professor with Imperial College London, who led the research, said in a news release.

“Most people will go through quite a raft of tests to get to a diagnosis of Alzheimer’s, and this tool may lead to a quicker diagnosis and reduce anxiety for patients,” he said.

Doctors may be able to use this information to refine and modify the diagnosis, he said.

To develop their method, researchers divided the brain into 115 regions and assessed each region for key features such as size, shape, and texture. Using machine learning, they trained an algorithm to identify where changes to these features could accurately predict the presence of Alzheimer’s disease.

This research addresses the “important” issue of early detection of Alzheimer’s disease, says Rebecca Edelmayer, PhD, senior director of scientific engagement for the Alzheimer’s Association.

“It is vital that individuals with Alzheimer’s be diagnosed early in the disease process when treatment may be most beneficial,” she says.

Early detection also allows people and their families more time to plan for the future, take part in clinical trials, and seek community resources, Edelmayer says.

But she cautions that this research is in its early days, and this tool is not ready to be used as a “standalone” test for Alzheimer’s but will need more testing in a more diverse group of people.

According to the Alzheimer’s Association, more than 6 million Americans have the disease. By 2050, this number is projected to rise to nearly 13 million.



Source link

Advertisement Banner
Previous Post

B2B telehealth company SteadyMD acquires credentialing platform BlocHealth

Next Post

Clinical trial software startup Florence Healthcare raises $27M

Next Post

Clinical trial software startup Florence Healthcare raises $27M

Discussion about this post

Recommended

BioTissue provides update on latest developments, technology

4 weeks ago

CDC Warns About Potentially Deadly Virus in Infants

3 weeks ago

Don't Miss

New and Noteworthy: What I Read This Week—Edition 188

August 6, 2022

Researchers feel AI could help in measuring snooze time, Health News, ET HealthWorld

August 6, 2022

Long Covid Symptoms Affect One In Eight, Study Suggests

August 6, 2022

Can Consuming Micronutrients Affect Ulcerative Colitis Risk?

August 6, 2022

© 2022 Pharma News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy.

Navigate Site

  • News
  • Medicine
  • Health Tech
  • Health Tech
  • Health Living
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Medicine
  • Health Tech
  • Health Living
  • Contact

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.